Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Author(s): Stein Michael F, Parsons Eric
Issue: Jul/Aug 2003 - After the Women's Health Initiative Trial
View All Articles in Issue
Page(s): 272-275
Download in electronic PDF format for $75
Abstract: This article reviews the effects of an oral solution of Rhus toxicodendron extract taken by patients during 2002 for prevention of contact allergic dermatitis. The solution used in this study was a concentration of 0.0001% Rhus toxicodendron (6X/12X) A sublingual dose of 3 mL was given on day 0, day 7 and day 14, followed by a maintenance dose of 3 mL, given at monthly intervals for 7 more doses. Instructions were to hold the solution under the tongue for 30 seconds and to swallow any remaining solution. Therapy was to be initiated before March and continued through September (although this did not always occur). A total of 73 patients were prescribed the oral solutions, 58 of whom could be contacted for follow-up. Two of these had not had a poison-ivy reaction in he previous year and so were excluded from the results. Of the remaining 56 patients, 25 (44.6%) had no poison-ivy reaction for the year with the oral solution. An additional 27 (48.2%) either reported a reaction that was less severe or reported fewer poison-ivy reactions for the year with the oral solution. Of the 58 patients, 56 (96.6%) said they would use the product again, 54 (93.1%) said they would recommend the product to a family member or friend, and 54 (93.1%) said they would recommend to their physician that he or she prescribe this medication for other patients. Only one patient reported mild facial flushing. The authors conclude that a dilute solution of Rhus toxicodendron dosed orally shows promise as an effective method for controlling reactions caused by poison ivy, poison oak and poison sumac, with 52 of 56 patients reporting reduced severity in symptoms associated with allergic contact dermatitis.
Related Keywords:
Contact allergic dermatitis, poison ivy, prevention of, Contact dermatitis, poison ivy, prevention of, Poison ivy, prevention of, Rhus toxicodendron, in the prevention of poison ivy
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Stein Michael F, Parsons Eric
|
Jul/Aug 2003
Pg. 272-275
|
Treating Patients Allergic to Poison Ivy
Karolchyk Scott
|
Nov/Dec 1998
Pg. 421
|
Poison Ivy Extract Injection (10-mcg/mL)
Karolchyk Scott
|
Nov/Dec 1998
Pg. 421
|
Poison Ivy Gel with 1% Hydrocortisone
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 50
|
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
|
Jan/Feb 2022
Pg. 6-8
|
Pediatric Dermatitis
Remmert Renee
|
Nov/Dec 2002
Pg. 419-421
|
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
|
May/Jun 2006
Pg. 172
|
Migraine: A General Approach to Prevention and Treatment
Kennedy Bonnie M
|
Sep/Oct 2006
Pg. 344-350
|
Quality Assurance: Compounding Record Audits for Error Prevention
Hawkins Jessica
|
May/Jun 2023
Pg. 211-217
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Canine Methylpyrazole Solution for Ethylene Glycol Poisoning
Allen Loyd V Jr
|
Jul/Aug 1997
Pg. 255
|
Dimercaptosuccinic Acid: Summary of Evidence
Carvin Jamarius, Thompson Tara
|
Mar/Apr 2023
Pg. 94-96
|
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Williams LaVonn
|
Jul/Aug 2018
Pg. 284-287
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
|
Jan/Feb 2019
Pg. 14-21
|
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Estrogen in the Treatment and Prevention of Alzheimer's Disease
Paganini-Hill Annlia, Henderson Victor W
|
Jan/Feb 1998
Pg. 24-29
|
Xylitol in the Prevention of Otitis Media
Glasnapp Andrew
|
May/Jun 2000
Pg. 171-174
|
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices
Kastango Eric S, Trissel Lawrence A, Bradshaw Brian D
|
Sep/Oct 2003
Pg. 401-416
|
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP
Bottoni Don J
|
Jan/Feb 2004
Pg. 22-27
|
Return to Top |